![Thomas Balzer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Förmögenhet: - $ per 2026-08-31
Thomas Balzer is currently Chief Medical Officer & SVP-Clinical Development at Lakewood-Amedex Biotherapeutics, Inc. since 2023.
Formerly, Dr. Balzer was Vice President at Bayer U.S.
LLC.
Education includes a doctorate from Freie Universität Berlin.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-07-30 | 0 ( -.--% ) | - $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| LAKEWOOD-AMEDEX BIOTHERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2022-11-01 |
| Företag | Position | Slut |
|---|---|---|
Bayer U.S. LLC
 Bayer U.S. LLC Information Technology ServicesTechnology Services Provides information technology services | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 3 |
|---|---|
Freie Universität Berlin
 Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amedex Therapeutics, Inc.
 Amedex Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on discovery and development of novel antimicrobial therapeutics | Health Technology |
Bayer U.S. LLC
Bayer U.S. LLC Information Technology ServicesTechnology Services Provides information technology services | Technology Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån
